Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 9, 2023

Total Value: $151M (100.0% shares, 0.0% debt)

Holdings (16)

BBIO BridgeBio Pharma Inc. (BBIO) 30.5%

Value $46.24M Shares 6,068,125 Est. Cost $40.43 Unrealized -76.3%

— Verona Pharma plc (VRNA) 23.0%

Value $34.82M Shares 1,332,485 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 17.2%

Value $26.09M Shares 1,025,000 Est. Cost $10.24 Unrealized +127.8%

GLUE Monte Rosa Therapeutics Inc. (GLUE) 7.4%

Value $11.2M Shares 1,472,331 Est. Cost $20.37 Unrealized -59.1%

ACRS Aclaris Theraputics Inc. (ACRS) 4.5%

Value $6.843M Shares 434,455 Est. Cost $10.31 Unrealized +56.1%

BMEA Biomea Fusion Inc. (BMEA) 4.4%

Value $6.734M Shares 798,757 Est. Cost $17.65 Unrealized -51.7%

— Poseida Therapeutics Inc. (PSTX) 3.7%

Value $5.529M Shares 1,043,267 Est. Cost $8.87 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 3.2%

Value $4.879M Shares 2,541,009 Est. Cost $11.18 Unrealized -81.9%

— Elevation Oncology Inc. (ELEV) 1.8%

Value $2.693M Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Reneo Pharmaceuticals Inc. (RPHM) 1.4%

Value $2.065M Shares 886,075 Est. Cost $9.33 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 0.9%

Value $1.322M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 0.6%

Value $849K Shares 3,142,857 Est. Cost $4.35 Unrealized —

— Aeglea Biotherapeutics Inc. (AGLE) 0.5%

Value $761K Shares 1,691,151 Est. Cost $8.00 Unrealized —

— AVROBIO, Inc. (AVRO) 0.5%

Value $717K Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.3%

Value $421K Shares 288,571 Est. Cost $11.34 Unrealized —

— Atreca Inc. (BCEL) 0.2%

Value $311K Shares 387,653 Est. Cost $18.84 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$46.24M	30.5%	$40.43	-76.3%	COM	10806X102
—	Verona Pharma plc (VRNA)	1,332,485	$34.82M	23.0%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$26.09M	17.2%	$10.24	+127.8%	COM	87164F105
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$11.2M	7.4%	$20.37	-59.1%	COM	61225M102
ACRS	Aclaris Theraputics Inc. (ACRS)	434,455	$6.843M	4.5%	$10.31	+56.1%	COM	00461U105
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$6.734M	4.4%	$17.65	-51.7%	COM	09077A106
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$5.529M	3.7%	$8.87	—	COM	73730P108
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$4.879M	3.2%	$11.18	-81.9%	COM CL A	67080N101
—	Elevation Oncology Inc. (ELEV)	2,834,910	$2.693M	1.8%	$13.57	—	COM	28623U101
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$2.065M	1.4%	$9.33	—	COM	75974E103
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$1.322M	0.9%	$24.31	—	COM	85209E109
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$849K	0.6%	$4.35	—	COM	57055L107
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$761K	0.5%	$8.00	—	COM	00773J103
—	AVROBIO, Inc. (AVRO)	1,009,779	$717K	0.5%	$16.72	—	COM	05455M100
—	Viracta Therapeutics Inc. (VIRX)	288,571	$421K	0.3%	$11.34	—	COM	92765F108
—	Atreca Inc. (BCEL)	387,653	$311K	0.2%	$18.84	—	CL A COM	04965G109